Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression

J. A. McCart, M. Puhlmann, J. Lee, Y. Hu, S. K. Libutti, H. R. Alexander, D. L. Bartlett

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Replicating viruses for cancer gene therapy have beneficial antitumor effects, however, in the setting of an enzyme/prodrug system, the interactions between these viruses and the activated agents are complex. A replicating vaccinia virus expressing the cytosine deaminase gene (VVCD), which converts the prodrug 5-FC into 5-FU, was characterized in vitro and in vivo for its antitumor effects and pathogenicity. Replicating VVCD (±5-FC) at various MOIs was used to infect MC38 murine Colon adenocarcinoma cells. At high MOIs (>0.1) virus alone was able to kill the majority (65-90%) of cells by day 5 with no additional benefit from prodrug. At low MOIs only the effect of prodrug is seen. Cell lysates demonstrated 300-fold reduced viral recovery from cells treated with both VVCD and 5-FC compared with controls treated with virus alone. Nude mice bearing subcutaneous MC38 tumors were injected with VVCD (or control) and treated with 5FC or control. Mice injected with VVCD (with or without 5FC treatment) had smaller tumors than the controls, suggesting that replicating vaccinia alone is cytotoxic to tumors in vivo. The addition of 5-FC improved the antitumor response when a low dose of virus was injected into tumors. Also, compared with mice that received virus alone, those that received VVCD and 5FC had significantly prolonged survival from virus-mediated death. In conclusion, the addition of an enzyme/prodrug system to a replicating virus can improve the antitumor response and decrease viral pathogenicity.

Original languageEnglish (US)
Pages (from-to)1217-1223
Number of pages7
JournalGene Therapy
Volume7
Issue number14
StatePublished - 2000
Externally publishedYes

Fingerprint

Vaccinia
Cytosine Deaminase
Prodrugs
Vaccinia virus
Viruses
Enzymes
Neoplasms
Genes
Virulence
Neoplasm Genes
Nude Mice
Fluorouracil
Genetic Therapy
Colon
Adenocarcinoma

Keywords

  • Cytosine deaminase
  • Enzyme/prodrug
  • Gene therapy
  • Replicating vaccinia virus

ASJC Scopus subject areas

  • Genetics

Cite this

McCart, J. A., Puhlmann, M., Lee, J., Hu, Y., Libutti, S. K., Alexander, H. R., & Bartlett, D. L. (2000). Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression. Gene Therapy, 7(14), 1217-1223.

Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression. / McCart, J. A.; Puhlmann, M.; Lee, J.; Hu, Y.; Libutti, S. K.; Alexander, H. R.; Bartlett, D. L.

In: Gene Therapy, Vol. 7, No. 14, 2000, p. 1217-1223.

Research output: Contribution to journalArticle

McCart, JA, Puhlmann, M, Lee, J, Hu, Y, Libutti, SK, Alexander, HR & Bartlett, DL 2000, 'Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression', Gene Therapy, vol. 7, no. 14, pp. 1217-1223.
McCart, J. A. ; Puhlmann, M. ; Lee, J. ; Hu, Y. ; Libutti, S. K. ; Alexander, H. R. ; Bartlett, D. L. / Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression. In: Gene Therapy. 2000 ; Vol. 7, No. 14. pp. 1217-1223.
@article{848e344068734db6a1afd649af11c300,
title = "Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression",
abstract = "Replicating viruses for cancer gene therapy have beneficial antitumor effects, however, in the setting of an enzyme/prodrug system, the interactions between these viruses and the activated agents are complex. A replicating vaccinia virus expressing the cytosine deaminase gene (VVCD), which converts the prodrug 5-FC into 5-FU, was characterized in vitro and in vivo for its antitumor effects and pathogenicity. Replicating VVCD (±5-FC) at various MOIs was used to infect MC38 murine Colon adenocarcinoma cells. At high MOIs (>0.1) virus alone was able to kill the majority (65-90{\%}) of cells by day 5 with no additional benefit from prodrug. At low MOIs only the effect of prodrug is seen. Cell lysates demonstrated 300-fold reduced viral recovery from cells treated with both VVCD and 5-FC compared with controls treated with virus alone. Nude mice bearing subcutaneous MC38 tumors were injected with VVCD (or control) and treated with 5FC or control. Mice injected with VVCD (with or without 5FC treatment) had smaller tumors than the controls, suggesting that replicating vaccinia alone is cytotoxic to tumors in vivo. The addition of 5-FC improved the antitumor response when a low dose of virus was injected into tumors. Also, compared with mice that received virus alone, those that received VVCD and 5FC had significantly prolonged survival from virus-mediated death. In conclusion, the addition of an enzyme/prodrug system to a replicating virus can improve the antitumor response and decrease viral pathogenicity.",
keywords = "Cytosine deaminase, Enzyme/prodrug, Gene therapy, Replicating vaccinia virus",
author = "McCart, {J. A.} and M. Puhlmann and J. Lee and Y. Hu and Libutti, {S. K.} and Alexander, {H. R.} and Bartlett, {D. L.}",
year = "2000",
language = "English (US)",
volume = "7",
pages = "1217--1223",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "14",

}

TY - JOUR

T1 - Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression

AU - McCart, J. A.

AU - Puhlmann, M.

AU - Lee, J.

AU - Hu, Y.

AU - Libutti, S. K.

AU - Alexander, H. R.

AU - Bartlett, D. L.

PY - 2000

Y1 - 2000

N2 - Replicating viruses for cancer gene therapy have beneficial antitumor effects, however, in the setting of an enzyme/prodrug system, the interactions between these viruses and the activated agents are complex. A replicating vaccinia virus expressing the cytosine deaminase gene (VVCD), which converts the prodrug 5-FC into 5-FU, was characterized in vitro and in vivo for its antitumor effects and pathogenicity. Replicating VVCD (±5-FC) at various MOIs was used to infect MC38 murine Colon adenocarcinoma cells. At high MOIs (>0.1) virus alone was able to kill the majority (65-90%) of cells by day 5 with no additional benefit from prodrug. At low MOIs only the effect of prodrug is seen. Cell lysates demonstrated 300-fold reduced viral recovery from cells treated with both VVCD and 5-FC compared with controls treated with virus alone. Nude mice bearing subcutaneous MC38 tumors were injected with VVCD (or control) and treated with 5FC or control. Mice injected with VVCD (with or without 5FC treatment) had smaller tumors than the controls, suggesting that replicating vaccinia alone is cytotoxic to tumors in vivo. The addition of 5-FC improved the antitumor response when a low dose of virus was injected into tumors. Also, compared with mice that received virus alone, those that received VVCD and 5FC had significantly prolonged survival from virus-mediated death. In conclusion, the addition of an enzyme/prodrug system to a replicating virus can improve the antitumor response and decrease viral pathogenicity.

AB - Replicating viruses for cancer gene therapy have beneficial antitumor effects, however, in the setting of an enzyme/prodrug system, the interactions between these viruses and the activated agents are complex. A replicating vaccinia virus expressing the cytosine deaminase gene (VVCD), which converts the prodrug 5-FC into 5-FU, was characterized in vitro and in vivo for its antitumor effects and pathogenicity. Replicating VVCD (±5-FC) at various MOIs was used to infect MC38 murine Colon adenocarcinoma cells. At high MOIs (>0.1) virus alone was able to kill the majority (65-90%) of cells by day 5 with no additional benefit from prodrug. At low MOIs only the effect of prodrug is seen. Cell lysates demonstrated 300-fold reduced viral recovery from cells treated with both VVCD and 5-FC compared with controls treated with virus alone. Nude mice bearing subcutaneous MC38 tumors were injected with VVCD (or control) and treated with 5FC or control. Mice injected with VVCD (with or without 5FC treatment) had smaller tumors than the controls, suggesting that replicating vaccinia alone is cytotoxic to tumors in vivo. The addition of 5-FC improved the antitumor response when a low dose of virus was injected into tumors. Also, compared with mice that received virus alone, those that received VVCD and 5FC had significantly prolonged survival from virus-mediated death. In conclusion, the addition of an enzyme/prodrug system to a replicating virus can improve the antitumor response and decrease viral pathogenicity.

KW - Cytosine deaminase

KW - Enzyme/prodrug

KW - Gene therapy

KW - Replicating vaccinia virus

UR - http://www.scopus.com/inward/record.url?scp=0033929022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033929022&partnerID=8YFLogxK

M3 - Article

C2 - 10918490

AN - SCOPUS:0033929022

VL - 7

SP - 1217

EP - 1223

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 14

ER -